Abingworth’s CRISPR Therapeutics CRSP Stock Holding History

Abingworth’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-259,599	Closed	-$21.7M	–	16
2020 Q3	$21.7M	Sell	259,599 -259,599	-50%	-$23M	4.64%	5
2020 Q2	$38.1M	Hold	519,198	–	–	10.64%	4
2020 Q1	$22M	Hold	519,198	–	–	14.58%	3
2019 Q4	$31.6M	Sell	519,198 -109,200	-17%	-$5.96M	15.28%	3
2019 Q3	$25.7M	Sell	628,398 -542,870	-46%	-$25.9M	16.28%	2
2019 Q2	$55M	Hold	1,171,268	–	–	21.11%	2
2019 Q1	$41.8M	Hold	1,171,268	–	–	37.43%	1
2018 Q4	$33.5M	Sell	1,171,268 -65,934	-5%	-$2.29M	30.41%	1
2018 Q3	$54.9M	Hold	1,237,202	–	–	32.61%	1
2018 Q2	$72.7M	Sell	1,237,202 -650,000	-34%	-$37M	41.53%	1
2018 Q1	$86.2M	Sell	1,887,202 -64,157	-3%	-$2.65M	53.59%	1
2017 Q4	$45.8M	Sell	1,951,359 -20,548	-1%	-$390K	33.18%	1
2017 Q3	$35.1M	Sell	1,971,907 -472,902	-19%	-$8.57M	24.33%	1
2017 Q2	$39M	Sell	2,444,809 -157,005	-6%	-$2.59M	31.01%	1
2017 Q1	$56.6M	Hold	2,601,814	–	–	42.2%	1
2016 Q4	$52M	Buy	+2,601,814	New	+$48.6M	43.5%	1

Other funds holding CRSP

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return